Furthermore, the prevalence rate of MACE was significantly higher in CAD patients with TSG-6 ≥ 19 ng/mL (40%, 10/25 cases) than the rate in those with TSG-6 < 19 ng/mL (20%, 22/110 cases) (Figure 6B). The gene discussed is TNFAIP6; the disease is coronary artery disorder.